Loading
Loading…
Loading…
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
1 Sept 2026, 2:00 pm6d left
PROCUREMENT OF DRUGS AND CONSUMABLES
9729252
GEM/2026/B/7894281
Two Packet Bid
Povidone Iodine solution 5 percent bott of 100 ml,Enoxaparin 60 mg per 0 point 6 ml Inj,Omeprazole
Poonch, Jammu And Kashmir
Total value wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
80%
Exempted
Yes
8 Aug 2026
8 Aug 2026
1 Sept 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Povidone Iodine solution 5 percent bott of 100 ml | 300 | Bott | Poonch | 21 |
| 2 | Enoxaparin 60 mg per 0 point 6 ml Inj | 100 | PFS | Poonch | 21 |
| 3 | Omeprazole 20 mg plus Domperidone 10 mg Cap | 3,000 | No | Poonch | 21 |
| 4 | Glucose Solution 5 percent in nontoxic disposable plastic bott of 500 ml FFS | 50 | Bott | Poonch | 21 |
| 5 | Mometasone 0 point 1 percent cream tube of 10 gm | 300 | Tube | Poonch | 21 |
| 6 | Etophylline BP 84 point 7 mg and Theophylline IP 25 point 3 mg per ml 2 ml Inj | 200 | Amp | Poonch | 21 |
| 7 | Dicyclomine HCL 20 mg Inj | 200 | Amp | Poonch | 21 |
| 8 | Methyl Prednisolone Sodium Succinate 1000 mg Inj | 50 | Vial | Poonch | 21 |
| 9 | Sodium Bicarbonate 7 point 5 percent Inj 10 ml amp | 200 | Amp | Poonch | 21 |
| 10 | Oxcarbazepine 150 mg Tab | 300 | No | Poonch | 21 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9729252.pdf
GEM_BID • 0.15 MB
boq_65121_2026-08-08-13-15-13_386d22bbd8ce25a37297dd39fea8ef05.pdf
BOQ • 0.35 MB
boq_item_sample_file-12_2026-08-08-13-15-13_fa3db2d20cfc9ca962a8a97847cebbd5.csv
BOQ • 0.00 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].